BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 17644084)

  • 21. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
    Wiley JL; Martin BR
    Chem Phys Lipids; 2002 Dec; 121(1-2):57-63. PubMed ID: 12505690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.
    Klugmann M; Klippenstein V; Leweke FM; Spanagel R; Schneider M
    Int J Neuropsychopharmacol; 2011 May; 14(4):505-17. PubMed ID: 21211107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice.
    Berrendero F; Mendizábal V; Murtra P; Kieffer BL; Maldonado R
    Eur J Neurosci; 2003 Oct; 18(8):2197-202. PubMed ID: 14622180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
    Silva GB; Atchison DK; Juncos LI; García NH
    Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring.
    Shabani M; Hosseinmardi N; Haghani M; Shaibani V; Janahmadi M
    Neuroscience; 2011 Jan; 172():139-52. PubMed ID: 20969930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice.
    Gould GG; Seillier A; Weiss G; Giuffrida A; Burke TF; Hensler JG; Rock C; Tristan A; McMahon LR; Salazar A; O'Connor JC; Satsangi N; Satsangi RK; Gu TT; Treat K; Smolik C; Schultz ST
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):260-9. PubMed ID: 22542870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.
    Antonelli T; Tomasini MC; Tattoli M; Cassano T; Tanganelli S; Finetti S; Mazzoni E; Trabace L; Steardo L; Cuomo V; Ferraro L
    Cereb Cortex; 2005 Dec; 15(12):2013-20. PubMed ID: 15788701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2.
    Nallapaneni A; Liu J; Karanth S; Pope C
    Toxicology; 2006 Oct; 227(1-2):173-83. PubMed ID: 16956707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity.
    Hill MN; Barr AM; Ho WS; Carrier EJ; Gorzalka BB; Hillard CJ
    J Neurochem; 2007 Oct; 103(1):47-56. PubMed ID: 17561935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
    Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
    Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
    Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
    Su SH; Wang YQ; Wu YF; Wang DP; Lin Q; Hai J
    Behav Brain Res; 2016 Oct; 313():334-344. PubMed ID: 27424778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
    Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G
    Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
    Benagiano V; Lorusso L; Flace P; Girolamo F; Rizzi A; Sabatini R; Auteri P; Bosco L; Cagiano R; Ambrosi G
    Neuroscience; 2007 Nov; 149(3):592-601. PubMed ID: 17916407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.